ClearPoint Neuro Completes Acquisition of IRRAS
ACCESS Newswire (Thu, 20-Nov 5:00 PM ET)
Market Chameleon (Fri, 7-Nov 2:08 AM ET)
ClearPoint Neuro Reports Third Quarter 2025 Results
ACCESS Newswire (Thu, 6-Nov 4:55 PM ET)
ClearPoint Neuro Announces Agreement to Acquire IRRAS
ACCESS Newswire (Thu, 6-Nov 4:51 PM ET)
ACCESS Newswire (Wed, 5-Nov 5:03 PM ET)
ACCESS Newswire (Tue, 7-Oct 4:15 PM ET)
ACCESS Newswire (Mon, 6-Oct 4:10 PM ET)
Market Chameleon (Fri, 3-Oct 6:42 AM ET)
ACCESS Newswire (Wed, 1-Oct 4:05 PM ET)
Market Chameleon (Fri, 26-Sep 4:36 AM ET)
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Clearpoint Neuro trades on the NASDAQ stock market under the symbol CLPT.
As of December 15, 2025, CLPT stock price declined to $12.63 with 291,279 million shares trading.
CLPT has a beta of 1.65, meaning it tends to be more sensitive to market movements. CLPT has a correlation of 0.09 to the broad based SPY ETF.
CLPT has a market cap of $375.72 million. This is considered a Small Cap stock.
Last quarter Clearpoint Neuro reported $9 million in Revenue and -$.21 earnings per share. This fell short of revenue expectation by $-859,000 and missed earnings estimates by -$.01.
In the last 3 years, CLPT traded as high as $30.10 and as low as $4.05.
The top ETF exchange traded funds that CLPT belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWO.
CLPT has underperformed the market in the last year with a price return of -23.0% while the SPY ETF gained +13.9%. However, in the short term, CLPT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +20.4% vs +3.9% return in SPY. But in the last 2 weeks, CLPT shares have been beat by the market, returning -12.7% compared to an SPY return of -0.4%.
CLPT support price is $12.21 and resistance is $13.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLPT shares will trade within this expected range on the day.
